Ibrance 75mg
USES:
Palbociclib is shown for the treatment of postmenopausal ladies with estrogen receptor (ER)- positive, human epidermal development factor receptor 2 (HER2)- negative propelled bosom malignant growth as a beginning endocrine-based treatment for their metastatic disease1. It is shown in the mix with an aromatase inhibitor (a hormonal treatment) as beginning endocrine based treatment in postmenopausal ladies or fulvestrant in ladies with ailment movement following endocrine therapy.
